we sought to improve the prediction of DM in NPC patients by developing a novel combined classifier to stratified patients into high-risk and low-risk groups with significant differences in 5-year survival. To our best of knowledge, our study is the first to integrate intratumor heterogeneity with EBV DNA for predicting DM in NPC patients, and found the combined classifier achieved superior prognostic performance than either the radiomic signatures or the clinical variables alone, which with a higher AUC, sensitivity, and specificity improvement.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords